FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 42346

FusionGeneSummary for YLPM1_KHDRBS2

check button Fusion gene summary
Fusion gene informationFusion gene name: YLPM1_KHDRBS2
Fusion gene ID: 42346
HgeneTgene
Gene symbol

YLPM1

KHDRBS2

Gene ID

56252

202559

Gene nameYLP motif containing 1KH RNA binding domain containing, signal transduction associated 2
SynonymsC14orf170|PPP1R169|ZAP113|ZAP3SLM-1|SLM1
Cytomap

14q24.3

6q11.1

Type of geneprotein-codingprotein-coding
DescriptionYLP motif-containing protein 1nuclear protein ZAP3protein phosphatase 1, regulatory subunit 169KH domain-containing, RNA-binding, signal transduction-associated protein 2KH domain containing, RNA binding, signal transduction associated 2Sam68-like mammalian protein 1
Modification date2018051920180522
UniProtAcc

P49750

Q5VWX1

Ensembl transtripts involved in fusion geneENST00000238571, ENST00000325680, 
ENST00000552421, ENST00000546901, 
ENST00000281156, 
Fusion gene scores* DoF score5 X 8 X 2=806 X 6 X 6=216
# samples 96
** MAII scorelog2(9/80*10)=0.169925001442312
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(6/216*10)=-1.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: YLPM1 [Title/Abstract] AND KHDRBS2 [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotation
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID

check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
TCGALDSARCTCGA-SI-A71O-01AYLPM1chr14

75291010

+KHDRBS2chr6

62442669

-
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
intron-3CDSENST00000238571ENST00000281156YLPM1chr14

75291010

+KHDRBS2chr6

62442669

-
Frame-shiftENST00000325680ENST00000281156YLPM1chr14

75291010

+KHDRBS2chr6

62442669

-
Frame-shiftENST00000552421ENST00000281156YLPM1chr14

75291010

+KHDRBS2chr6

62442669

-
3UTR-3CDSENST00000546901ENST00000281156YLPM1chr14

75291010

+KHDRBS2chr6

62442669

-

Top

FusionProtFeatures for YLPM1_KHDRBS2


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
YLPM1

P49750

KHDRBS2

Q5VWX1

Plays a role in the reduction of telomerase activityduring differentiation of embryonic stem cells by binding to thecore promoter of TERT and controlling its down-regulation.{ECO:0000250}. RNA-binding protein that plays a role in the regulationof alternative splicing and influences mRNA splice site selectionand exon inclusion. Binds both poly(A) and poly(U) homopolymers.Phosphorylation by PTK6 inhibits its RNA-binding ability (Bysimilarity). Induces an increased concentration-dependentincorporation of exon in CD44 pre-mRNA by direct binding topurine-rich exonic enhancer. Can regulate alternative splicing ofNRXN1 in the laminin G-like domain 6 containing the evolutionaryconserved neurexin alternative spliced segment 4 (AS4) involved inneurexin selective targeting to postsynaptic partners. Regulatescell-type specific alternative splicing of NRXN1 at AS4 and actssynergystically with SAM68 in exon skipping. In contrast actsantagonistically with SAM68 in NRXN3 exon skipping at AS4. Itsphosphorylation by FYN inhibits its ability to regulate splicesite selection. May function as an adapter protein for Src kinasesduring mitosis. {ECO:0000250|UniProtKB:Q920F3,ECO:0000250|UniProtKB:Q9WU01}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for YLPM1_KHDRBS2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.

* Fusion transcript sequences (only coding sequence (CDS) region).

* Fusion transcript sequences (Full-length transcript).

Top

FusionGenePPI for YLPM1_KHDRBS2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors
YLPM1PRMT1, CHGB, USP7, USP45, WDR48, MLH1, SRGAP2, RB1CC1, CACNA1A, PPP1CA, ITSN2, SIRT7, CUL3, SPDL1, SPG21, RINT1, PPP1CC, DAB2, HDAC11, GRB2, NONO, PRPF40A, APBB1, WWOX, LGR4, DROSHA, OBSL1, BMI1, PPP1R3A, SMARCC1, SMARCC2, DDX17, B9D2, HNRNPA1, PPP1CB, MATR3, CDC5L, MAGEE1, P4HA3, NAGK, NCK2, FOXA1, HEY1KHDRBS2EWSR1, RBMX, HNRNPK, KHDRBS3, RPAP2, DDX17, DDX5, HNRNPA1, HNRNPA2B1, HNRNPH1, HNRNPR, SYNCRIP, HNRNPC, IGF2BP1, PRMT1, ILF2, KHDRBS1, HNRNPDL, EHBP1, ARID2, TAF3, DSG1, HNRNPA0, IGF2BP3, HNRNPL, HNRNPUL2, RBM39, ILF3, HNRNPH3, PRMT5, RPS3, FGA, YBX1, FGG, HNRNPD, MRPS27, TARDBP, NUSAP1, SAFB, WDR77, MOV10, HRNR, FGB, DEK, FBXW11, LRRC15, HSP90AB1, LYN, CIRBP, DOCK2, HBZ, PTK6, RBM3, SDCBP, SPG7, SULT1A3, TYK2, MTA1, CHTOP, PRPF31, NPDC1, NCOA5, AEN, NABP1, PRR3, YTHDC1, CATSPER1, ZFC3H1, KHDRBS2, LINC01018, TYMSOS, ATXN2, DDX43, TMEM14B, BTRC, ATG7, WDR45B, YRDC, CRBN, PLCG1, PTER, ACOX1, CAPG, RFWD2, CUL1, SUPT5H, KLHL42, USP7, CTC1, SUZ12, ACAD11, NAGK, FOXA3, ACAA1, MAPK3, AURKA, MVK


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for YLPM1_KHDRBS2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

RelatedDiseases for YLPM1_KHDRBS2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneKHDRBS2C0025202melanoma1CTD_human